A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer
Clinical trial NCT05186506 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05186506
- Sponsor
- Sichuan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2025-12-15
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.